Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 724353, 8 pages
Original Article

Treatment of Idiopathic Parkinson's Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study

School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong

Received 25 April 2009; Accepted 17 July 2009

Copyright © 2011 Wan Fung Kum et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Nussbaum and C. E. Ellis, “Alzheimer's disease and Parkinson's disease,” The New England Journal of Medicine, vol. 348, no. 14, pp. 1356–1364, 2003. View at Publisher · View at Google Scholar · View at PubMed
  2. J. Woo, E. Lau, E. Ziea, and D. K. Y. Chan, “Prevalence of Parkinson's disease in a Chinese population,” Acta Neurologica Scandinavica, vol. 109, no. 3, pp. 228–231, 2004. View at Publisher · View at Google Scholar
  3. G. R. Williams, L. T. Kurland, and I. D. Goldberg, “Morbidity and mortality with parkinsonism,” Journal of Neurosurgery, vol. 24, pp. 138–143, 1966. View at Google Scholar
  4. J. Jankovic, “Complications and limitations of drug therapy for Parkinson's disease,” Neurology, vol. 55, no. 12, pp. S2–S6, 2000. View at Google Scholar
  5. J. E. Ahlskog and M. D. Muenter, “Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature,” Movement Disorders, vol. 16, no. 3, pp. 448–458, 2001. View at Publisher · View at Google Scholar
  6. E. Miyawaki, K. Lyons, R. Pahwa et al., “Motor complications of chronic levodopa therapy in Parkinson's disease,” Clinical Neuropharmacology, vol. 20, no. 6, pp. 523–530, 1997. View at Google Scholar
  7. P. R. Rajendran, R. E. Thompson, and S. G. Reich, “The use of alternative therapies by patients with Parkinson's disease,” Neurology, vol. 57, no. 5, pp. 790–794, 2001. View at Google Scholar
  8. V. Chung, L. Liu, Z. Bian et al., “Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review,” Movement Disorders, vol. 21, no. 10, pp. 1709–1715, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. T. Ishikawa, T. Funahashi, and J. Kudo, “Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism,” Psychiatry and Clinical Neurosciences, vol. 54, no. 5, pp. 579–582, 2000. View at Publisher · View at Google Scholar · View at PubMed
  10. T. K. Huang and D. B. Zhang, “Extrapyramidal disease,” in Neuropathy and Psychosis of Traditional Chinese Medicine, pp. 426–427, Chinese Medical Science Publishers, Beijing, China, 2000. View at Google Scholar
  11. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Google Scholar
  12. X. Y. Zheng, “The guidance for clinical research of TCM syndrome,” in The Guidance for Clinical Research of New Chinese Herbal Medicine, pp. 361–364, Chinese Medical Scientific Publishers, Beijing, China, 2002. View at Google Scholar
  13. K.-L. Tsang, I. Chi, S.-L. Ho, V. W. Lou, T. M. C. Lee, and L.-W. Chu, “Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease,” Movement Disorders, vol. 17, no. 5, pp. 1036–1040, 2002. View at Publisher · View at Google Scholar · View at PubMed
  14. S. Fahn, R. L. Elton, and U. D. Committee, “Unified Parkinson,” in Recent Developments in Parkinson's Disease, S. Fahn, C. D. Marsden, and D. B. Calne, Eds., vol. 2, pp. 153–173, Macmillan Healthcare Information, Florham Park, NJ, USA, 1987. View at Google Scholar
  15. C. L. K. Lam, B. Gandek, X. S. Ren, and M. S. Chan, “Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey,” Journal of Clinical Epidemiology, vol. 51, no. 11, pp. 1139–1147, 1998. View at Publisher · View at Google Scholar
  16. H. F. Chiu, H. C. Lee, Y. K. Wing, P. K. Kwong, C. M. Leung, and D. W. Chung, “Reliability, validity and structure of the Chinese Geriatric Depression Scale in a Hong Kong context: a preliminary report,” Singapore Medical Journal, vol. 35, no. 5, pp. 477–480, 1994. View at Google Scholar
  17. H. Reichmann, J. Boas, D. MacMahon, V. Myllyla, A. Hakala, and K. Reinikainen, “Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations,” Acta Neurologica Scandinavica, vol. 111, no. 1, pp. 21–28, 2005. View at Publisher · View at Google Scholar · View at PubMed
  18. R. Fitzpatrick, J. M. Norquist, and C. Jenkinson, “Distribution-based criteria for change in health-related quality of life in Parkinson's disease,” Journal of Clinical Epidemiology, vol. 57, no. 1, pp. 40–44, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. Q. Li, D. Zhao, and E. Bezard, “Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature,” Behavioural Pharmacology, vol. 17, no. 5-6, pp. 403–410, 2006. View at Publisher · View at Google Scholar
  20. W. F. Zhu, S. Y. Ye, and H. L. Zhang, “A clinical trial of Zhenzhanning in treating Parkinson's disease,” Journal of Shanxi College of Traditional Chinese Medicine, vol. 5, pp. 22–23, 2004. View at Google Scholar
  21. L. Cui, X. D. Yu, and J. Cui, “Clinical observation on effects of combined therapy of Bushen Pingchan Recipe and Medopa Tablet in treating Parkinson's disease,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 23, pp. 504–507, 2003. View at Google Scholar
  22. Z. Y. Wang, “Treatment of 38 cases Parkinson's disease patients with Gui Ling Pa An Wan,” Traditional Chinese Medicine Research, vol. 18, pp. 37–38, 2005. View at Google Scholar
  23. X.-D. Yu, L. Cui, and C. Biao, “Quantitative evaluation of self-made Bushenpingchan formula combined with madopar for Parkinson disease,” Chinese Journal of Clinical Rehabilitation, vol. 10, no. 35, pp. 160–162, 2006. View at Google Scholar
  24. Y. Hiyama, T. Nakao, and M. Yomota, “Effects of Liu Jun Zhi Tang on patients with Parkinson's disease who manifested motor fluctuations on levodopa therapy,” Sect Chin Med Foreign Med Sci, vol. 14, pp. 1–3, 1992. View at Google Scholar
  25. U. K. Rinne, V. Sonninen, and T. Siirtola, “Plasma concentration of levodopa in patients with Parkinson's disease. Response to administration of levodopa alone or combined with a decarboxylase inhibitor and clinical correlations,” European Neurology, vol. 10, no. 5, pp. 301–310, 1973. View at Google Scholar
  26. J. A. Logemann, H. B. Fisher, B. Boshes, and E. R. Blonsky, “Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients,” Journal of Speech and Hearing Disorders, vol. 43, no. 1, pp. 47–57, 1978. View at Google Scholar
  27. L. Hartelius and P. Svensson, “Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey,” Folia Phoniatrica et Logopaedica, vol. 46, no. 1, pp. 9–17, 1994. View at Google Scholar
  28. A. K. Ho, R. Iansek, C. Marigliani, J. L. Bradshaw, and S. Gates, “Speech impairment in a large sample of patients with Parkinson's disease,” Behavioural Neurology, vol. 11, no. 3, pp. 131–137, 1998. View at Google Scholar
  29. N. Miller, E. Noble, D. Jones, and D. Burn, “Life with communication changes in Parkinson's disease,” Age and Ageing, vol. 35, no. 3, pp. 235–239, 2006. View at Publisher · View at Google Scholar · View at PubMed
  30. Z. H. Cao, F. L. Li, and Y. S. Zhang, “Effects of Naokangtai capsule on sixty-two cases Parkinson's disease,” Chinese Journal of Clinical Pharmacology and Therapeutics, vol. 7, pp. 75–76, 2002. View at Google Scholar
  31. J. C. McCroskey and L. L. McCroskey, “Self-report as an approach to measuring communication competence,” Communication Research Reports, vol. 5, no. 2, pp. 108–113, 1988. View at Publisher · View at Google Scholar
  32. Z.-X. Bian, D. Moher, S. Dagenais et al., “Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality,” Journal of Chinese Integrative Medicine, vol. 4, no. 3, pp. 233–242, 2006. View at Publisher · View at Google Scholar